Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 17/20 | 0.72 |
| ▸ | ROCK1 | Q13464 | 15/20 | 0.72 |
| ▸ | AKT2 | P31751 | 10/20 | 0.72 |
| ▸ | RPS6KA5 | O75582 | 10/20 | 0.72 |
| ▸ | AKT3 | Q9Y243 | 7/20 | 0.72 |
| ▸ | RPS6KA1 | Q15418 | 12/20 | 0.64 |
| ▸ | CIT | O14578 | 1/20 | 0.58 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.58 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.58 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.58 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.58 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.58 |
| ▸ | ULK1 | O75385 | 1/20 | 0.58 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.58 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.58 |
| ▸ | SMC2 | O95347 | 1/20 | 0.58 |
| ▸ | LATS1 | O95835 | 1/20 | 0.58 |
| ▸ | PAK4 | O96013 | 1/20 | 0.58 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.58 |
| ▸ | PRKCB | P05771 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL691292 | 0.95 | AKT1 (0.66) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL12837971 | 0.86 | AKT1 (0.72) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL4066128 | 0.86 | AKT1 (0.69) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL4066386 | 0.85 | AKT1 (0.56) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL4072293 | 0.85 | AKT1 (0.62) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL3487791 | 0.85 | AKT1 (0.54) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL4715048 | 0.84 | RPS6KA5 (1.00) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL10053680 | 0.83 | AKT1 (0.91) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL4685637 | 0.82 | ROCK1 (0.53) | AKT1ROCK1AKT2RPS6KA5AKT3 | |
| SCHEMBL690257 | 0.82 | ROCK1 (0.54) | AKT1ROCK1AKT2RPS6KA5AKT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2286232-B1 | METHODS FOR THE IDENTIFICATION OF PARP INTERACTING MOLECULES AND FOR PURIFICATION OF PARP PROTEINS | CELLZOME AG (DE) | 2012-02-29 | — | — | EP | disclosed |
| CN-102027371-A | Methods for the identification of PARP interacting molecules and for purification of PARP proteins | CELLZOME AG | 2011-04-20 | — | — | CN | disclosed |
| US-20110070595-A1 | METHODS FOR THE IDENTIFICATION OF PARP INTERACTING MOLECULES AND FOR PURIFICATION OF PARP PROTEINS | CELLZOME AG | 2011-03-24 | — | — | US | disclosed |
| US-20110070595-A1 | METHODS FOR THE IDENTIFICATION OF PARP INTERACTING MOLECULES AND FOR PURIFICATION OF PARP PROTEINS | CELLZOME AG | 2011-03-24 | — | — | US | disclosed |
| WO-2009138229-A1 | METHODS FOR THE IDENTIFICATION OF PARP INTERACTING MOLECULES AND FOR PURIFICATION OF PARP PROTEINS | CELLZOME AG (DE) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070595-A1 | METHODS FOR THE IDENTIFICATION OF PARP INTERACTING MOLECULES AND FOR PURIFICATION OF PARP PROTEINS | PARP3, PARP11, PARP12 | AKT1 2738/4885ROCK1 2576/4885AKT2 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.